These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37900960)
1. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up. Skaudickas D; Lenčiauskas P; Skaudickas A; Undžytė G Open Med (Wars); 2023; 18(1):20230832. PubMed ID: 37900960 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients. Sokmen D; Comez YI Aging Male; 2023 Dec; 26(1):2253876. PubMed ID: 37671978 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study. Kim KS; Choi YS; Bae WJ; Cho HJ; Ha US; Hong SH; Lee JY; Ahn ST; Moon DG; Kim SW World J Mens Health; 2022 Jul; 40(3):473-480. PubMed ID: 34448374 [TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome. Skaudickas D; Telksnys T; Veikutis V; Aniulis P; Jievaltas M Open Med (Wars); 2020; 15(1):580-585. PubMed ID: 33336014 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy. Guu SJ; Geng JH; Chao IT; Lin HT; Lee YC; Juan YS; Liu CC; Wang CJ; Tsai CC Am J Mens Health; 2018 Mar; 12(2):441-452. PubMed ID: 29072124 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Kong X; Hu W; Dong Z; Tian J; Wang Y; Jin C; Liang C; Hao Z; Wang Z Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):483-494. PubMed ID: 35798855 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients. Sokmen D; Comez YI Urol Int; 2023; 107(9):872-876. PubMed ID: 37611558 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis. Yuan P; Ma D; Zhang Y; Gao X; Liu Z; Li R; Wang T; Wang S; Liu J; Liu X Neurourol Urodyn; 2019 Aug; 38(6):1457-1466. PubMed ID: 31037757 [TBL] [Abstract][Full Text] [Related]
11. The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave. Kong X; Dong Z; Hu W; Mi J; Xiao J; Wang Y; Chen W; Pei Z; Hao Z; Liang C; Wang Q; Wang Z Prostate; 2024 Dec; 84(16):1525-1536. PubMed ID: 39308020 [TBL] [Abstract][Full Text] [Related]
12. Comparing two different low-intensity shockwave therapy frequency protocols for nonbacterial chronic prostatitis/chronic pelvic pain syndrome: A two-arm, parallel-group randomized controlled trial. Mykoniatis I; Pyrgidis N; Kalyvianakis D; Zilotis F; Kapoteli P; Fournaraki A; Hatzichristou D Prostate; 2021 Jun; 81(9):499-507. PubMed ID: 33929052 [TBL] [Abstract][Full Text] [Related]
13. Extracorporeal shock wave therapy in association with bromelain and escin for the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome. Palmieri A; Cai T; Di Luise L; D'Alterio C; La Cava G; Cirigliano L; Di Giovanni A; Gallelli L; Capece M Biomed Rep; 2023 Jan; 18(1):7. PubMed ID: 36544851 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal Shockwave Therapy (ESWT) Alleviates Pain, Enhances Erectile Function and Improves Quality of Life in Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Wu WL; Bamodu OA; Wang YH; Hu SW; Tzou KY; Yeh CT; Wu CC J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441902 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms: An open-label, single-arm trial. Jin C; Zhang S; Mo F; Zhang M; Meng J; Bian Z; Fu Z; Fang Q; Kong X; Feng B; Wang Z; Jiang Z; Chen M; Zhang L; Song Z; Hao Z; Liang C Andrologia; 2022 Feb; 54(1):e14260. PubMed ID: 34585431 [TBL] [Abstract][Full Text] [Related]
16. Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial. Sakr AM; Fawzi AM; Kamel M; Ali MM Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):93-99. PubMed ID: 34635804 [TBL] [Abstract][Full Text] [Related]
17. Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis. Al Edwan GM; Muheilan MM; Atta ON Ann Med Surg (Lond); 2017 Feb; 14():12-17. PubMed ID: 28119778 [TBL] [Abstract][Full Text] [Related]
18. Low-intensity extracorporeal shock wave therapy for male chronic pelvic pain syndrome: a systematic review and meta-analysis. Li G; Man L Transl Androl Urol; 2021 Mar; 10(3):1202-1211. PubMed ID: 33850755 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Mykoniatis I; Kalyvianakis D; Zilotis F; Kapoteli P; Fournaraki A; Poulios E; Hatzichristou D Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):370-379. PubMed ID: 32989261 [TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Safety of Extracorporeal Shockwave Therapy versus Acupuncture in the Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Evidence Based on a Network Meta-analysis. Kang Y; Song P; Cao D; Di X; Lu Y; Liu P; Dong Q Am J Mens Health; 2021; 15(6):15579883211057998. PubMed ID: 34911370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]